1. Home
  2. AADI vs CLIR Comparison

AADI vs CLIR Comparison

Compare AADI & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • CLIR
  • Stock Information
  • Founded
  • AADI 2011
  • CLIR 2008
  • Country
  • AADI United States
  • CLIR United States
  • Employees
  • AADI N/A
  • CLIR N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • CLIR Industrial Machinery/Components
  • Sector
  • AADI Health Care
  • CLIR Industrials
  • Exchange
  • AADI Nasdaq
  • CLIR Nasdaq
  • Market Cap
  • AADI 33.6M
  • CLIR 35.0M
  • IPO Year
  • AADI N/A
  • CLIR 2012
  • Fundamental
  • Price
  • AADI $1.56
  • CLIR $0.82
  • Analyst Decision
  • AADI Buy
  • CLIR Strong Buy
  • Analyst Count
  • AADI 2
  • CLIR 1
  • Target Price
  • AADI $5.00
  • CLIR $6.00
  • AVG Volume (30 Days)
  • AADI 340.3K
  • CLIR 139.8K
  • Earning Date
  • AADI 08-07-2024
  • CLIR 08-29-2024
  • Dividend Yield
  • AADI N/A
  • CLIR N/A
  • EPS Growth
  • AADI N/A
  • CLIR N/A
  • EPS
  • AADI N/A
  • CLIR N/A
  • Revenue
  • AADI $23,840,000.00
  • CLIR $2,611,000.00
  • Revenue This Year
  • AADI $4.21
  • CLIR $146.94
  • Revenue Next Year
  • AADI $8.61
  • CLIR N/A
  • P/E Ratio
  • AADI N/A
  • CLIR N/A
  • Revenue Growth
  • AADI 26.97
  • CLIR 105.91
  • 52 Week Low
  • AADI $1.28
  • CLIR $0.62
  • 52 Week High
  • AADI $7.24
  • CLIR $1.72
  • Technical
  • Relative Strength Index (RSI)
  • AADI 46.27
  • CLIR 48.21
  • Support Level
  • AADI $1.32
  • CLIR $0.79
  • Resistance Level
  • AADI $1.55
  • CLIR $0.95
  • Average True Range (ATR)
  • AADI 0.10
  • CLIR 0.08
  • MACD
  • AADI 0.01
  • CLIR 0.00
  • Stochastic Oscillator
  • AADI 46.15
  • CLIR 54.55

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: